Credit Suisse’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$838K Sell
72,841
-8,073
-10% -$68.6K ﹤0.01% 2375
2023
Q4
$590K Buy
80,914
+12,963
+19% +$102K ﹤0.01% 2648
2023
Q3
$618K Sell
67,951
-2,347
-3% -$28.1K ﹤0.01% 2570
2023
Q2
$856K Sell
70,298
-5,962
-8% -$66.4K ﹤0.01% 2494
2023
Q1
$948K Buy
76,260
+2,030
+3% +$37.3K ﹤0.01% 2364
2022
Q4
$1.43M Buy
74,230
+4,241
+6% +$89.7K ﹤0.01% 2093
2022
Q3
$1.31M Buy
69,989
+17,333
+33% +$356K ﹤0.01% 2130
2022
Q2
$951K Sell
52,656
-6,391
-11% -$104K ﹤0.01% 2428
2022
Q1
$946K Sell
59,047
-974
-2% -$17.5K ﹤0.01% 2583
2021
Q4
$1.47M Sell
60,021
-1,858
-3% -$43.6K ﹤0.01% 3023
2021
Q3
$1.44M Sell
61,879
-7,593
-11% -$184K ﹤0.01% 3058
2021
Q2
$1.9M Buy
69,472
+60,099
+641% +$1.71M ﹤0.01% 2903
2021
Q1
$345K Buy
9,373
+2,409
+35% +$85.1K ﹤0.01% 3950
2020
Q4
$261K Buy
+6,964
New +$215K ﹤0.01% 4025

Other funds holding AHCO

Credit Suisse's AHCO Position: Q1 2024 in Review

Credit Suisse reduced its AdaptHealth (AHCO) stake by 10% in Q1 2024, selling an estimated $68.6K and leaving 72,841 shares worth $838K. The position accounts for ﹤0.01% of the portfolio, ranked #2375.

Credit Suisse first reported a position in AHCO in Q4 2020 and has held it in 14 quarters since. The position peaked at $1.9M in Q2 2021. 210 funds tracked by Wall St. Rank hold AHCO as of Q1 2024.

  • Credit Suisse held 72,841 shares of AdaptHealth worth $838K as of Q1 2024.
  • Credit Suisse sold 8,073 AdaptHealth shares in Q1 2024, an estimated $68.6K.
  • AdaptHealth made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2375 holding.
  • Credit Suisse first reported a position in AdaptHealth in Q4 2020 and has held it in 14 quarters since.
  • Credit Suisse's AdaptHealth position peaked at $1.9M in Q2 2021.
  • 210 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.